RCM
BSX icon

Requisite Capital Management’s Boston Scientific BSX Stock Holding History

Requisite Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$303K Buy
4,832
+32
+0.7% +$2.56K 0.06% 81
2025
Q4 		$458K Buy
+4,800
New +$471K 0.09% 69

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Requisite Capital Management's BSX Position: Q1 2026 in Review

Requisite Capital Management increased its Boston Scientific (BSX) stake by 0.67% in Q1 2026, buying an estimated $2.56K and bringing the position to 4,832 shares worth $303K. The position accounts for 0.06% of the portfolio, ranked #81.

Requisite Capital Management first reported a position in BSX in Q4 2025 and has held it in 2 quarters since. The position peaked at $458K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Requisite Capital Management held 4,832 shares of Boston Scientific worth $303K as of Q1 2026.
  • Requisite Capital Management bought 32 Boston Scientific shares in Q1 2026, an estimated $2.56K.
  • Boston Scientific made up 0.06% of Requisite Capital Management's portfolio in Q1 2026, its #81 holding.
  • Requisite Capital Management first reported a position in Boston Scientific in Q4 2025 and has held it in 2 quarters since.
  • Requisite Capital Management's Boston Scientific position peaked at $458K in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Requisite Capital Management's 13F filing for Q1 2026, filed 14 May 2026.